Erratum in: Budget Impact Analysis of anakinra in the treatment of patients with Still's Disease

Glob Reg Health Technol Assess. 2020 Sep 30:7:91. doi: 10.33393/grhta.2020.2187. eCollection 2020 Jan-Dec.

Authors

Roberto Ravasio¹, Roberto Giacomelli², Stefano Bianchi³

Affiliations

¹ Health Publishing & Services S.r.l., Milan - Italy.
² Department of Biotechnological and Applied Clinical Science, Rheumatology Unit, School of Medicine, University of L'Aquila, L'Aquila - Italy.
³ Unità Operativa Servizio farmaceutico ospedaliero e territoriale Azienda Usl Ferrara - Italy.

Abstract

[This corrects the article DOI: 10.33393/grhta.2020.2140.].

Copyright © 2020, The Authors.

Publication types

Published Erratum